Jakarta, INTI - Mark Zuckerberg, the founder of Facebook and CEO of Meta, is reportedly developing an artificial intelligence version of himself.
According to a source familiar with the matter, Zuckerberg is using the company’s AI technology to create a digital persona modeled after him. This virtual version is being trained on his behavior and public statements.
The AI is also expected to learn his views on current company strategy, according to a report from Bloomberg.
Eventually, employees may be able to interact with a digital version of their CEO.
Meta reportedly hopes this AI version of Zuckerberg will allow him to stay more connected with employees by receiving more frequent, concise updates in digital form than would be possible in person.
Zuckerberg’s Vision, Work Style, and History of Innovation
For Zuckerberg, delegating tasks to his AI counterpart could free up more time for the activities that originally drove his success.
A person familiar with the company said Zuckerberg is already spending more time in Meta’s AI labs and coding for five to ten hours per week.
The idea of a digital Zuckerberg may sound like something out of a movie, or even a satirical headline, but he is known for taking bold and unconventional risks.
When he attempted to expand Facebook into China, he learned Mandarin. During the rise of messaging bots and early AI assistants, he built a personal home assistant system that he could control from his phone.
During the COVID-19 pandemic, when Meta heavily emphasized remote work, Zuckerberg also held many meetings in the metaverse.
Conclusion
The reported development of an AI version of Mark Zuckerberg reflects a broader trend of integrating artificial intelligence into executive decision-making and workplace communication. While still unconventional, it highlights Meta’s ambition to push the boundaries of digital interaction and productivity. If realized, such innovation could redefine how leaders engage with teams in the future of work.
Read more: OpenAI Introduces GPT-Rosalind to Support Life Sciences Research